Merck prevails in US safety litigation over Gardasil HPV vaccine
A federal judge ruled in favor of Merck in litigation accusing it of concealing the risks of Gardasil, a vaccine to prevent ...
MRK Investors Have Opportunity to Lead Merck & Co., Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today!
NEW YORK, NY / ACCESS Newswire / April 4, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, ...
Merck & Co., Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information – MRK
NEW YORK, NY / ACCESS Newswire / April 4, 2025 / If you suffered a loss on your Merck & Co., Inc. (NYSE:MRK) investment and want to learn ...
FiercePharma23d
Merck defeats claims it should have added safety warnings to Gardasil's label, knocking out 200-plus lawsuits
In what’s shaping up to be a red-letter week for Gardasil, Merck & Co. has simultaneously opened a massive new manufacturing facility for the human papillomavirus (HPV) shot in the U.S. and put ...
2 Beaten-Down Stocks to Buy and Hold for a Decade
Recent market volatility notwithstanding, equities generally deliver solid returns over long periods, like a decade. The key ...
The Business Journals25d
Gardasil maker completes $1B North Carolina expansion — more growth on the way
A global health care company is growing its footprint in Durham with a new manufacturing facility. STORY HIGHLIGHTS Merck opens new vaccine facility in Durham. New facility will manufacture HPV ...
Merck & Co.: Looming Patent Expiries For Key Drugs Weaken Longer-Term Outlook
Merck's revenues are driven by cancer med Keytruda, which faces patent expiry by 2028. See why I rate MRK stock a hold.
Amgen and Merck: The P/E ratio
Within that group, biotechnology giant Amgen (NASDAQ: AMGN) has been the best-performing stock in 2025, returning an ...
Positive phase III data gives Merck potential boost for blockbuster Keytruda in injection form
When topline phase III data was released in November, hinting at the potential of success, Jefferies analyst Akash Tiwari ...
Is Merck Stock a Bargain Buy?
Despite this potential, the stock has fallen by 25% in the past 12 months -- so is it a bargain buy right now? During the ...
The Zacks Analyst Blog Highlights Amazon.com, Oracle and Merck
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research ...
New Hampshire Union Leader25d
Merck prevails in safety litigation over Gardasil HPV vaccine
A federal judge ruled in favor of Merck in litigation accusing it of concealing the risks of Gardasil, a vaccine to prevent cervical and other cancers caused by the human papillomavirus and one of ...